Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Navigating The 7 Biggest Challenges In Rare Disease Clinical Trials
Discover how partnering with specialized rare disease CROs allows drug sponsors to accelerate treatment development, navigate trial complexities, and ultimately improve patient outcomes.
3 Essential Components Of Successful Renal And Hepatic Impairment Studies
Kidney and liver function affect how drugs work in the body. Learn how impairment studies help set safe, effective dosing for these patients.
Big Futures For Emerging Biopharma: Navigating Biotech Hurdles
Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.
A Sponsor's Guide To Evaluating CRO Data Governance
Evaluate CRO data governance with a risk-based framework that strengthens data quality, traceability, compliance, and regulatory readiness.

Urgent Compliance Recovery Following Vendor Transition
5/26/2026

Strong local leadership, clear ownership, and governed oversight drove rapid remediation of legacy safety gaps, restoring regulatory confidence and safeguarding market continuity.
Finding The Right CRO Partner For Early-Stage Oncology Trials
11/21/2025

Discover how a data-driven CRO selection framework can replace manual processes, minimize bias, and build stronger, more collaborative sponsor–vendor relationships.
Why Protocol‑Driven eSource Solves Data Capture For 80% Of Sites
2/6/2026

Designing data capture around study protocols boosts data quality and real‑time visibility. Reducing transcription and aligning workflows helps teams improve compliance and speed decisions.
Increasing Efficiency And Reducing Drug Waste
10/2/2025

Discover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
The Team For Your Package Design Needs
8/16/2025

Our dedicated team of in-house design specialists deliver insightful packaging design and practical knowledge to deliver differentiated and cost-effective packaging solutions.

Accelerate Drug Development With Innovative 360˚ CDMO And CRO Solutions

Accelerator™ Drug Development provides a strategic, end-to-end partnership model that helps sponsors optimize resources, overcome development challenges, and advance promising therapies.
Turnkey Solutions For Your Renal And Hepatic Impairment Studies

With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
Clinical Trial Supply Services: End-To-End Patient-Ready IMP Delivery

At the center of every clinical trial is a patient waiting for a treatment to arrive safely, securely, and on time. Clinical trial supply services make that possible by ensuring investigational medicinal products (IMPs) are packaged, labeled, stored, and distributed in full regulatory compliance across global study sites
An FSP Model Can Minimize The Risks Of Failure And Missed Milestones

Specialized, demand-driven resourcing from Veristat ensures a clinical team’s focus remains where it should be: meeting study milestones and accelerating time to market.
Immune Challenge Models For Early Drug Development

Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.